Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymorphone IR for Acute Postoperative Pain in Pediatric Subjects
NCT00801398Phase 3Completed
- Sponsor
- Endo International plc
- Start
- Feb 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of oxymorphone in postoperative pain, sponsored by Endo International plc. Primary endpoints: Visual Analog Scale of Pain Intensity Change From Baseline at 48 hours and Subjects Taking Rescue Medication at 48 hours. Started Feb 2009; status: completed.
02
Drugs
oxymorphone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT00801398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801398.